UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004546
Receipt number R000005431
Scientific Title Comparative study of remifentanil-propofol with dexmedetomidine versus without dexmedetomidine for tracheobronchial stent insertion
Date of disclosure of the study information 2010/11/12
Last modified on 2013/01/19 21:54:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative study of remifentanil-propofol with dexmedetomidine versus without dexmedetomidine for tracheobronchial stent insertion

Acronym

Comparative study of remifentanil-propofol with dexmedetomidine versus without dexmedetomidine for tracheobronchial stent insertion

Scientific Title

Comparative study of remifentanil-propofol with dexmedetomidine versus without dexmedetomidine for tracheobronchial stent insertion

Scientific Title:Acronym

Comparative study of remifentanil-propofol with dexmedetomidine versus without dexmedetomidine for tracheobronchial stent insertion

Region

Japan


Condition

Condition

Patients with tracheobronchial stenosis undergoing tracheobronchial stent insertion under general anesthesia

Classification by specialty

Pneumology Anesthesiology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of dexmedetomidine for anesthetic management tracheobronchial stent insertion

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

hemodynamics,respiratory condition,sedative condition,total dose of anesthesia,duration of anesthetic induction,duration of emergence

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

conventional anesthetic management with propofol and remifentanil

Interventions/Control_2

combined with conventional anesthetic and dexmedetomidine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patient undergoing tracheobronchial stent insertion under general anesthesia
2)Patient over 20 years old
3)Written informed consent from the patient

Key exclusion criteria

1)Patients with bradycardia(HR<50/min)
2)Patients with 2 or 3 AVblock
3)Patients with heart failure
4)Patients with nustable angina pectoris
5)Patients with severe liver disfunction
6)Patients with severe renal disfunction

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriko Akasaka

Organization

St.Marianna University School of Medicine

Division name

Department of Anesthesiology

Zip code


Address

2-16-1 Sugao Miyamae-ku,Kawasaki Kanagawa

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

St.Marianna University School of Medicine

Division name

Department of Anesthesiology

Zip code


Address

2-16-1 Sugao Miyamae-ku,Kawasaki Kanagawa

TEL


Homepage URL


Email



Sponsor or person

Institute

St.Marianna University School of Medicine Department of Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

St.Marianna University School of Medicine Department of Anesthesiology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 10 Month 15 Day

Date of IRB


Anticipated trial start date

2010 Year 11 Month 01 Day

Last follow-up date

2012 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 11 Month 12 Day

Last modified on

2013 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005431


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name